LOK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O43615 | T106 | Sugiyama | TIMM44 MIMT44 TIM44 | DEARRLEEsDVLQEARRKyKtIESETVRTSEVLRKKLGELT |
| O43615 | Y104 | Sugiyama | TIMM44 MIMT44 TIM44 | FRDEARRLEEsDVLQEARRKyKtIESETVRTSEVLRKKLGE |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O94804 | S438 | Sugiyama | STK10 LOK | MDARIQVAQEKQVAEQGGDLsPAANRsQKAsQsRPNssALE |
| O94804 | S444 | Sugiyama | STK10 LOK | VAQEKQVAEQGGDLsPAANRsQKAsQsRPNssALEtLGGEK |
| O94804 | S448 | Sugiyama | STK10 LOK | KQVAEQGGDLsPAANRsQKAsQsRPNssALEtLGGEKLANG |
| O94804 | S450 | Sugiyama | STK10 LOK | VAEQGGDLsPAANRsQKAsQsRPNssALEtLGGEKLANGsL |
| O94804 | S454 | Sugiyama | STK10 LOK | GGDLsPAANRsQKAsQsRPNssALEtLGGEKLANGsLEPPA |
| O94804 | S455 | iPTMNet|EPSD|Sugiyama | STK10 LOK | GDLsPAANRsQKAsQsRPNssALEtLGGEKLANGsLEPPAQ |
| O94804 | S469 | Sugiyama | STK10 LOK | QsRPNssALEtLGGEKLANGsLEPPAQAAPGPSKRDsDCss |
| O94804 | S541 | Sugiyama | STK10 LOK | KLYKKTLKRTRKFVVDGVEVsITtsKIISEDEKKDEEMRFL |
| O94804 | S545 | Sugiyama | STK10 LOK | KTLKRTRKFVVDGVEVsITtsKIISEDEKKDEEMRFLRRQE |
| O94804 | S824 | Sugiyama | STK10 LOK | ARLPKIQRSEGKTRMAMYKKsLHINGGGSAAEQREKIKQFS |
| O94804 | S954 | Sugiyama | STK10 LOK | EQEMFFKLSEEAECPNPstPsKAAKFFPySSADAs______ |
| O94804 | S968 | Sugiyama | STK10 LOK | PNPstPsKAAKFFPySSADAs____________________ |
| O94804 | T459 | Sugiyama | STK10 LOK | PAANRsQKAsQsRPNssALEtLGGEKLANGsLEPPAQAAPG |
| O94804 | T544 | Sugiyama | STK10 LOK | KKTLKRTRKFVVDGVEVsITtsKIISEDEKKDEEMRFLRRQ |
| O94804 | T611 | Sugiyama | STK10 LOK | LEQMHKRFEQEINAKKKFFDtELENLERQQKQQVEKMEQDH |
| O94804 | T952 | Sugiyama | STK10 LOK | KREQEMFFKLSEEAECPNPstPsKAAKFFPySSADAs____ |
| O94804 | Y766 | Sugiyama | STK10 LOK | MEEHQLQERHQLVKQQLKDQyFLQRHELLRKHEKEREQMQR |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P15311 | T567 | EPSD|PSP | EZR VIL2 | RTHNDIIHNENMRQGRDKYKtLRQIRQGNTKQRIDEFEAL_ |
| P26038 | T558 | GPS6|SIGNOR|ELM|EPSD|PSP | MSN | KTANDMIHAENMRLGRDKYKtLRQIRQGNTKQRIDEFEsM_ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P35241 | T564 | EPSD|PSP | RDX | KTQNDVLHAENVKAGRDKYKtLRQIRQGNtKQRIDEFEAM_ |
| P35269 | T41 | Sugiyama | GTF2F1 RAP74 | NTTKKyNIMAFNAADKVNFAtWNQARLERDLSNKKIyQEEE |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P47756 | T202 | Sugiyama | CAPZB | SGsGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMEN |
| P53350 | T210 | GPS6|ELM|EPSD|PSP | PLK1 PLK | VKIGDFGLATKVEYDGERKKtLCGtPNyIAPEVLSKKGHSF |
| P55209 | T269 | Sugiyama | NAP1L1 NRP | GPEIMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVT |
| P55209 | T272 | Sugiyama | NAP1L1 NRP | IMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVTKTV |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| Q14697 | T40 | Sugiyama | GANAB G2AN KIAA0088 | LAFLGVCLGITLAVDRSNFKtCEEssFCKRQRsIRPGLsPy |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9ULW6 | T342 | Sugiyama | NAP1L2 BPX | GTAIEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVT |
| Q9ULW6 | T345 | Sugiyama | NAP1L2 BPX | IEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVTEDF |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9Y597 | T673 | Sugiyama | KCTD3 | sPLLARARRtEsFHSYRDFQtINLNRNVERAVPENGNLGPI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 1.357407e-09 | 8.867 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.762512e-08 | 7.322 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.056912e-08 | 7.094 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.601149e-06 | 5.444 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.664638e-06 | 5.436 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.038809e-06 | 5.219 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.000085e-06 | 5.046 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.076277e-05 | 4.968 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.429967e-05 | 4.845 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.217515e-05 | 4.654 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.584397e-05 | 4.588 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.908848e-05 | 4.408 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.310567e-05 | 4.365 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.310567e-05 | 4.365 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.867217e-05 | 4.313 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.456140e-05 | 4.263 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.268009e-05 | 4.139 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.093540e-05 | 4.092 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.093540e-05 | 4.092 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.401692e-05 | 4.076 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.915072e-05 | 4.050 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.147039e-04 | 3.940 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.147039e-04 | 3.940 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.147039e-04 | 3.940 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.147039e-04 | 3.940 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.147039e-04 | 3.940 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.019664e-04 | 3.992 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.779264e-05 | 4.010 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.779024e-04 | 3.750 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.779024e-04 | 3.750 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.761382e-04 | 3.754 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.763335e-04 | 3.754 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.957176e-04 | 3.708 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.921826e-04 | 3.716 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.099933e-04 | 3.678 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.577765e-04 | 3.589 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.865961e-04 | 3.543 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.140503e-04 | 3.503 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.403008e-04 | 3.468 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.413300e-04 | 3.467 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.538431e-04 | 3.451 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.138719e-04 | 3.383 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.165388e-04 | 3.380 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.471672e-04 | 3.350 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.471672e-04 | 3.350 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.472683e-04 | 3.349 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.546831e-04 | 3.342 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.309352e-04 | 3.275 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.309352e-04 | 3.275 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.309352e-04 | 3.275 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.309352e-04 | 3.275 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.689355e-04 | 3.329 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.291084e-04 | 3.276 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.941747e-04 | 3.306 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.546616e-04 | 3.256 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.546616e-04 | 3.256 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.279498e-04 | 3.277 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.259103e-04 | 3.279 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.259103e-04 | 3.279 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.217397e-04 | 3.206 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.217997e-04 | 3.206 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.679828e-04 | 3.175 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.707779e-04 | 3.173 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.707779e-04 | 3.173 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.735656e-04 | 3.172 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.221432e-04 | 3.141 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.735932e-04 | 3.111 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.207137e-04 | 3.036 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.718098e-04 | 3.012 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.867070e-04 | 3.006 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.150635e-03 | 2.939 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.181888e-03 | 2.927 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.397457e-03 | 2.855 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.428033e-03 | 2.845 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.503753e-03 | 2.823 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.572887e-03 | 2.803 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.606729e-03 | 2.794 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.797971e-03 | 2.745 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.913647e-03 | 2.718 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.028577e-03 | 2.693 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.071419e-03 | 2.684 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.085536e-03 | 2.681 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.103497e-03 | 2.677 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.125053e-03 | 2.673 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.385077e-03 | 2.622 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.462459e-03 | 2.609 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.526021e-03 | 2.598 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.526021e-03 | 2.598 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.825109e-03 | 2.549 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.825109e-03 | 2.549 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.825109e-03 | 2.549 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.916868e-03 | 2.535 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.958840e-03 | 2.529 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.106468e-03 | 2.508 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.220540e-03 | 2.492 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.106468e-03 | 2.508 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.152468e-03 | 2.501 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.493531e-03 | 2.457 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.643430e-03 | 2.438 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.777353e-03 | 2.423 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.032569e-03 | 2.394 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.488039e-03 | 2.348 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.611258e-03 | 2.336 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.900754e-03 | 2.310 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.400488e-03 | 2.268 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.736352e-03 | 2.241 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.977849e-03 | 2.223 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.084967e-03 | 2.216 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.219641e-03 | 2.206 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.746445e-03 | 2.171 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.926562e-03 | 2.159 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.406308e-03 | 2.193 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.746445e-03 | 2.171 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.938209e-03 | 2.159 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.411616e-03 | 2.130 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.858207e-03 | 2.105 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.078886e-03 | 2.093 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.297444e-03 | 2.081 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.618244e-03 | 2.065 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 8.641166e-03 | 2.063 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.479637e-03 | 2.023 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.001545e-02 | 1.999 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.108671e-02 | 1.955 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.108671e-02 | 1.955 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.044168e-02 | 1.981 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.110888e-02 | 1.954 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.113218e-02 | 1.953 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.122779e-02 | 1.950 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.122779e-02 | 1.950 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.137012e-02 | 1.944 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.143226e-02 | 1.942 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.143226e-02 | 1.942 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.143226e-02 | 1.942 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.186379e-02 | 1.926 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.342975e-02 | 1.872 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.342975e-02 | 1.872 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.342975e-02 | 1.872 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.342975e-02 | 1.872 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.254026e-02 | 1.902 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.326343e-02 | 1.877 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.326343e-02 | 1.877 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.395680e-02 | 1.855 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.467893e-02 | 1.833 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.472062e-02 | 1.832 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.490649e-02 | 1.827 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.490649e-02 | 1.827 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.506436e-02 | 1.822 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.676911e-02 | 1.775 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.548124e-02 | 1.810 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.702323e-02 | 1.769 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.694625e-02 | 1.771 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.526484e-02 | 1.816 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.676911e-02 | 1.775 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.702184e-02 | 1.769 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.711724e-02 | 1.767 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.733709e-02 | 1.761 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.749571e-02 | 1.757 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.819409e-02 | 1.740 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.826256e-02 | 1.738 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.826256e-02 | 1.738 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.847847e-02 | 1.733 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.871164e-02 | 1.728 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.886834e-02 | 1.724 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.906868e-02 | 1.720 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.949903e-02 | 1.710 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.949903e-02 | 1.710 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.965050e-02 | 1.707 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.073790e-02 | 1.683 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.233570e-02 | 1.651 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.111197e-02 | 1.675 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.037540e-02 | 1.691 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.111197e-02 | 1.675 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.037540e-02 | 1.691 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.073790e-02 | 1.683 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.146063e-02 | 1.668 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.248800e-02 | 1.648 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.272490e-02 | 1.643 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.272490e-02 | 1.643 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.272490e-02 | 1.643 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.272490e-02 | 1.643 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.272911e-02 | 1.643 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.335679e-02 | 1.632 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.388212e-02 | 1.622 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.484500e-02 | 1.605 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.484500e-02 | 1.605 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.484500e-02 | 1.605 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.581412e-02 | 1.588 | 1 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.651238e-02 | 1.577 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.694488e-02 | 1.570 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.159095e-02 | 1.500 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.159095e-02 | 1.500 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.159095e-02 | 1.500 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.159095e-02 | 1.500 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.926297e-02 | 1.534 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.926297e-02 | 1.534 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.932047e-02 | 1.533 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.932047e-02 | 1.533 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.014853e-02 | 1.521 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.004304e-02 | 1.522 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.708837e-02 | 1.567 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.745633e-02 | 1.561 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.905190e-02 | 1.537 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.708837e-02 | 1.567 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.014853e-02 | 1.521 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.196787e-02 | 1.495 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.305626e-02 | 1.481 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.368682e-02 | 1.473 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.836212e-02 | 1.416 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.836212e-02 | 1.416 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.712326e-02 | 1.430 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.548186e-02 | 1.450 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.708930e-02 | 1.431 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.708930e-02 | 1.431 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.785881e-02 | 1.422 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.836212e-02 | 1.416 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.460864e-02 | 1.461 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.460864e-02 | 1.461 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.836212e-02 | 1.416 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.610079e-02 | 1.442 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.664730e-02 | 1.436 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.535944e-02 | 1.451 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.033769e-02 | 1.394 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.548186e-02 | 1.450 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.030217e-02 | 1.395 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.883993e-02 | 1.411 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.712326e-02 | 1.430 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.883993e-02 | 1.411 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.757676e-02 | 1.425 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.781780e-02 | 1.422 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.851718e-02 | 1.414 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.046742e-02 | 1.393 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.587668e-02 | 1.445 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.712326e-02 | 1.430 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.057286e-02 | 1.392 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.565979e-02 | 1.448 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.851718e-02 | 1.414 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.756845e-02 | 1.425 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.146510e-02 | 1.382 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.173844e-02 | 1.379 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.173844e-02 | 1.379 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.173844e-02 | 1.379 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.173844e-02 | 1.379 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.225684e-02 | 1.374 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.238541e-02 | 1.373 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.238541e-02 | 1.373 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.421058e-02 | 1.354 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.452335e-02 | 1.351 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.452335e-02 | 1.351 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.452335e-02 | 1.351 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 4.485632e-02 | 1.348 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 4.485632e-02 | 1.348 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.485632e-02 | 1.348 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.485632e-02 | 1.348 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.608199e-02 | 1.336 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.655579e-02 | 1.332 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.655579e-02 | 1.332 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.755745e-02 | 1.323 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.836058e-02 | 1.316 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.837836e-02 | 1.315 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.868353e-02 | 1.313 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.989582e-02 | 1.302 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.989582e-02 | 1.302 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.004345e-02 | 1.301 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.114400e-02 | 1.291 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.292393e-02 | 1.276 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.292393e-02 | 1.276 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.292393e-02 | 1.276 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.292393e-02 | 1.276 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.292393e-02 | 1.276 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.367532e-02 | 1.270 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.503416e-02 | 1.187 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.503416e-02 | 1.187 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.571342e-02 | 1.182 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.727360e-02 | 1.172 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.874663e-02 | 1.231 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.503416e-02 | 1.187 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.613728e-02 | 1.251 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.727360e-02 | 1.172 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.176889e-02 | 1.209 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.574496e-02 | 1.182 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.503416e-02 | 1.187 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.613728e-02 | 1.251 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.415743e-02 | 1.266 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.415743e-02 | 1.266 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.503416e-02 | 1.187 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.821196e-02 | 1.235 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.846164e-02 | 1.233 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.745009e-02 | 1.171 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.763915e-02 | 1.170 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.763915e-02 | 1.170 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.763915e-02 | 1.170 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.763915e-02 | 1.170 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.763915e-02 | 1.170 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.763915e-02 | 1.170 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.787703e-02 | 1.168 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.814359e-02 | 1.167 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.111932e-02 | 1.148 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.115461e-02 | 1.148 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.251069e-02 | 1.140 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.363311e-02 | 1.133 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.363311e-02 | 1.133 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.363311e-02 | 1.133 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.363311e-02 | 1.133 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.490499e-02 | 1.125 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.533777e-02 | 1.123 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.731230e-02 | 1.112 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.731230e-02 | 1.112 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.756896e-02 | 1.110 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.796389e-02 | 1.108 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.796389e-02 | 1.108 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 7.796389e-02 | 1.108 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.946320e-02 | 1.100 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 8.770314e-02 | 1.057 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 8.770314e-02 | 1.057 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 8.770314e-02 | 1.057 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 9.161547e-02 | 1.038 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 9.161547e-02 | 1.038 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 9.161547e-02 | 1.038 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.058983e-01 | 0.975 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.195462e-02 | 1.086 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.066051e-02 | 1.043 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.066051e-02 | 1.043 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 1.091520e-01 | 0.962 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.644109e-02 | 1.063 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.282509e-02 | 1.082 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.120783e-02 | 1.040 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.046386e-01 | 0.980 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.973257e-02 | 1.001 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.058983e-01 | 0.975 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.823827e-02 | 1.054 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.058983e-01 | 0.975 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.962886e-02 | 1.002 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.058983e-01 | 0.975 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.714132e-02 | 1.013 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.695887e-02 | 1.061 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.823827e-02 | 1.054 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.068393e-01 | 0.971 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.068393e-01 | 0.971 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.770314e-02 | 1.057 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.058983e-01 | 0.975 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.962886e-02 | 1.002 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.282509e-02 | 1.082 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.928932e-02 | 1.049 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.973257e-02 | 1.001 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.557131e-02 | 1.020 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.071241e-01 | 0.970 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.281220e-02 | 1.082 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.266765e-02 | 1.033 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.574040e-02 | 1.019 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.120783e-02 | 1.040 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.032288e-01 | 0.986 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.973257e-02 | 1.001 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.063842e-01 | 0.973 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.058983e-01 | 0.975 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.066051e-02 | 1.043 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.066051e-02 | 1.043 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.494072e-02 | 1.023 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.055876e-01 | 0.976 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.700636e-02 | 1.013 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.101687e-02 | 1.041 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.096246e-01 | 0.960 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.096246e-01 | 0.960 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.117176e-01 | 0.952 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.142709e-01 | 0.942 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.142709e-01 | 0.942 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.162208e-01 | 0.935 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.171739e-01 | 0.931 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.188994e-01 | 0.925 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.188994e-01 | 0.925 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.207285e-01 | 0.918 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.207285e-01 | 0.918 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.207285e-01 | 0.918 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.207285e-01 | 0.918 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.224034e-01 | 0.912 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.252740e-01 | 0.902 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.281455e-01 | 0.892 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.286304e-01 | 0.891 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.286304e-01 | 0.891 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.286304e-01 | 0.891 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.286304e-01 | 0.891 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.286304e-01 | 0.891 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.286304e-01 | 0.891 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.286304e-01 | 0.891 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.286304e-01 | 0.891 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.289554e-01 | 0.890 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.289554e-01 | 0.890 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.297877e-01 | 0.887 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.360284e-01 | 0.866 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.360284e-01 | 0.866 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.360284e-01 | 0.866 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.360284e-01 | 0.866 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.360284e-01 | 0.866 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.360284e-01 | 0.866 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.365263e-01 | 0.865 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.677239e-01 | 0.775 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.677239e-01 | 0.775 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.677239e-01 | 0.775 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 1.677239e-01 | 0.775 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.677239e-01 | 0.775 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.677239e-01 | 0.775 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.677239e-01 | 0.775 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.677239e-01 | 0.775 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.677239e-01 | 0.775 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.677239e-01 | 0.775 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.677239e-01 | 0.775 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.677239e-01 | 0.775 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.677239e-01 | 0.775 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.677239e-01 | 0.775 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.677239e-01 | 0.775 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.050658e-01 | 0.688 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.050658e-01 | 0.688 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.050658e-01 | 0.688 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.050658e-01 | 0.688 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.517261e-01 | 0.819 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.517261e-01 | 0.819 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.517261e-01 | 0.819 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.840548e-01 | 0.735 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.005682e-01 | 0.698 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.607757e-01 | 0.794 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.461222e-01 | 0.835 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.946603e-01 | 0.711 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 1.946603e-01 | 0.711 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.736138e-01 | 0.760 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.840548e-01 | 0.735 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.739539e-01 | 0.760 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.831686e-01 | 0.737 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.461222e-01 | 0.835 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.718673e-01 | 0.765 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.719191e-01 | 0.765 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.677553e-01 | 0.775 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.840548e-01 | 0.735 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.840548e-01 | 0.735 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.403070e-01 | 0.853 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.899468e-01 | 0.721 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.899468e-01 | 0.721 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.899468e-01 | 0.721 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.840548e-01 | 0.735 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.725843e-01 | 0.763 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.831686e-01 | 0.737 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.378570e-01 | 0.861 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.707238e-01 | 0.768 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.517261e-01 | 0.819 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.677553e-01 | 0.775 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.050777e-01 | 0.688 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.050777e-01 | 0.688 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.050777e-01 | 0.688 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.050777e-01 | 0.688 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.907588e-01 | 0.720 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.694245e-01 | 0.771 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.677239e-01 | 0.775 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.517261e-01 | 0.819 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.840548e-01 | 0.735 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.607757e-01 | 0.794 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.628061e-01 | 0.788 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.778233e-01 | 0.750 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.628061e-01 | 0.788 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.778233e-01 | 0.750 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.469925e-01 | 0.833 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.499133e-01 | 0.824 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.653728e-01 | 0.782 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.856395e-01 | 0.731 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.387296e-01 | 0.858 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.050777e-01 | 0.688 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 1.718673e-01 | 0.765 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.896598e-01 | 0.722 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.785848e-01 | 0.748 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.677553e-01 | 0.775 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.050658e-01 | 0.688 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.005682e-01 | 0.698 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.831686e-01 | 0.737 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.452729e-01 | 0.838 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.831686e-01 | 0.737 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 2.050658e-01 | 0.688 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.607757e-01 | 0.794 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.393000e-01 | 0.856 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.677239e-01 | 0.775 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.050658e-01 | 0.688 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.831686e-01 | 0.737 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.794730e-01 | 0.746 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.005682e-01 | 0.698 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.426593e-01 | 0.846 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.049678e-01 | 0.688 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.734705e-01 | 0.761 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.005682e-01 | 0.698 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.664467e-01 | 0.779 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.628061e-01 | 0.788 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.499133e-01 | 0.824 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.946603e-01 | 0.711 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.850465e-01 | 0.733 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.906934e-01 | 0.720 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.677553e-01 | 0.775 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.377334e-01 | 0.861 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.063236e-01 | 0.685 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.063236e-01 | 0.685 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.063236e-01 | 0.685 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.063236e-01 | 0.685 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.407345e-01 | 0.618 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.407345e-01 | 0.618 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.407345e-01 | 0.618 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 2.407345e-01 | 0.618 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 2.748047e-01 | 0.561 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.748047e-01 | 0.561 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.748047e-01 | 0.561 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.748047e-01 | 0.561 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.073481e-01 | 0.512 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.073481e-01 | 0.512 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.073481e-01 | 0.512 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.073481e-01 | 0.512 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 3.073481e-01 | 0.512 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.073481e-01 | 0.512 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.384331e-01 | 0.471 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.384331e-01 | 0.471 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.172436e-01 | 0.663 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.172436e-01 | 0.663 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.172436e-01 | 0.663 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.340333e-01 | 0.631 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.340333e-01 | 0.631 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.681247e-01 | 0.434 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.681247e-01 | 0.434 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.681247e-01 | 0.434 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.681247e-01 | 0.434 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.964855e-01 | 0.402 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.964855e-01 | 0.402 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.964855e-01 | 0.402 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.964855e-01 | 0.402 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.846692e-01 | 0.546 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.421588e-01 | 0.616 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.182297e-01 | 0.661 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.665783e-01 | 0.574 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.788968e-01 | 0.555 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.515233e-01 | 0.454 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.679337e-01 | 0.434 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.295541e-01 | 0.639 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.295541e-01 | 0.639 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.161033e-01 | 0.500 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.548188e-01 | 0.594 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.002405e-01 | 0.398 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.781232e-01 | 0.422 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.885303e-01 | 0.540 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.583198e-01 | 0.588 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.159252e-01 | 0.500 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.159252e-01 | 0.500 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.439467e-01 | 0.464 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.439467e-01 | 0.464 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.787048e-01 | 0.422 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.036740e-01 | 0.518 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.181397e-01 | 0.661 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.300907e-01 | 0.638 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.349678e-01 | 0.475 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.349678e-01 | 0.475 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.036740e-01 | 0.518 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.119583e-01 | 0.674 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.677845e-01 | 0.572 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.677845e-01 | 0.572 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.300907e-01 | 0.638 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.533902e-01 | 0.452 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.159252e-01 | 0.500 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.846692e-01 | 0.546 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.421588e-01 | 0.616 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.681247e-01 | 0.434 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.573145e-01 | 0.590 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.376464e-01 | 0.624 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.846692e-01 | 0.546 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.912671e-01 | 0.536 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.182899e-01 | 0.497 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.280824e-01 | 0.484 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.665783e-01 | 0.574 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.340333e-01 | 0.631 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.340333e-01 | 0.631 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.204992e-01 | 0.657 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.407345e-01 | 0.618 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.846692e-01 | 0.546 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.841788e-01 | 0.415 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.501026e-01 | 0.602 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.243207e-01 | 0.649 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.337010e-01 | 0.631 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.349678e-01 | 0.475 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.748047e-01 | 0.561 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.748047e-01 | 0.561 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.748047e-01 | 0.561 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.681247e-01 | 0.434 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.300907e-01 | 0.638 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.912671e-01 | 0.536 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.131395e-01 | 0.671 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.489480e-01 | 0.457 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.904179e-01 | 0.408 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.148129e-01 | 0.382 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.790295e-01 | 0.554 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.924999e-01 | 0.406 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.673016e-01 | 0.573 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.748047e-01 | 0.561 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.073481e-01 | 0.512 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 2.172436e-01 | 0.663 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.172436e-01 | 0.663 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.677845e-01 | 0.572 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.657770e-01 | 0.437 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.781232e-01 | 0.422 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.360850e-01 | 0.474 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.846692e-01 | 0.546 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.816917e-01 | 0.550 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.657770e-01 | 0.437 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.386489e-01 | 0.470 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.846692e-01 | 0.546 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.096261e-01 | 0.679 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.015145e-01 | 0.521 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.181397e-01 | 0.661 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.407345e-01 | 0.618 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.748047e-01 | 0.561 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.748047e-01 | 0.561 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.073481e-01 | 0.512 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.384331e-01 | 0.471 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.384331e-01 | 0.471 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.340333e-01 | 0.631 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.964855e-01 | 0.402 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.964855e-01 | 0.402 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.181397e-01 | 0.661 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.773572e-01 | 0.557 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.841788e-01 | 0.415 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.489480e-01 | 0.457 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.798365e-01 | 0.420 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.587084e-01 | 0.587 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.982622e-01 | 0.525 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.982622e-01 | 0.525 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.876913e-01 | 0.412 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.418305e-01 | 0.616 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.576747e-01 | 0.589 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.508936e-01 | 0.601 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.964855e-01 | 0.402 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.181397e-01 | 0.661 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.665783e-01 | 0.574 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.912671e-01 | 0.536 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.657770e-01 | 0.437 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.657770e-01 | 0.437 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.952909e-01 | 0.530 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.073481e-01 | 0.512 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.172436e-01 | 0.663 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.543269e-01 | 0.595 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.665783e-01 | 0.574 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.894662e-01 | 0.538 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.003523e-01 | 0.398 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.112235e-01 | 0.507 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.112235e-01 | 0.507 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.182297e-01 | 0.661 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.515233e-01 | 0.454 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.154288e-01 | 0.501 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.340333e-01 | 0.631 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 3.841788e-01 | 0.415 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.341170e-01 | 0.631 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.570962e-01 | 0.590 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.665783e-01 | 0.574 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.364207e-01 | 0.626 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.386489e-01 | 0.470 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.045019e-01 | 0.393 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.407345e-01 | 0.618 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.748047e-01 | 0.561 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.073481e-01 | 0.512 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.073481e-01 | 0.512 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.340333e-01 | 0.631 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.681247e-01 | 0.434 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.681247e-01 | 0.434 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 2.508936e-01 | 0.601 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.964855e-01 | 0.402 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.964855e-01 | 0.402 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.964855e-01 | 0.402 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.912671e-01 | 0.536 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.131395e-01 | 0.671 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.002405e-01 | 0.398 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.180910e-01 | 0.497 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.787048e-01 | 0.422 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.959796e-01 | 0.529 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.720240e-01 | 0.565 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.078476e-01 | 0.512 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.901065e-01 | 0.409 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.285411e-01 | 0.483 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.729969e-01 | 0.564 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.161033e-01 | 0.500 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.073481e-01 | 0.512 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.243207e-01 | 0.649 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.904179e-01 | 0.408 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.928963e-01 | 0.533 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.161033e-01 | 0.500 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.161033e-01 | 0.500 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.172436e-01 | 0.663 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.515233e-01 | 0.454 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.885303e-01 | 0.540 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.751686e-01 | 0.560 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.045019e-01 | 0.393 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.828539e-01 | 0.548 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.172436e-01 | 0.663 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.172436e-01 | 0.663 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.798365e-01 | 0.420 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.026511e-01 | 0.395 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.713897e-01 | 0.430 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.407345e-01 | 0.618 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.748047e-01 | 0.561 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.748047e-01 | 0.561 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.748047e-01 | 0.561 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.073481e-01 | 0.512 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.340333e-01 | 0.631 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.681247e-01 | 0.434 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.681247e-01 | 0.434 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.964855e-01 | 0.402 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.421588e-01 | 0.616 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.515233e-01 | 0.454 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.894662e-01 | 0.538 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.177578e-01 | 0.662 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.364207e-01 | 0.626 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.241431e-01 | 0.489 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.912671e-01 | 0.536 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.710525e-01 | 0.567 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 3.904179e-01 | 0.408 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.748047e-01 | 0.561 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.073481e-01 | 0.512 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.073481e-01 | 0.512 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.384331e-01 | 0.471 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.681247e-01 | 0.434 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.508936e-01 | 0.601 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.673016e-01 | 0.573 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.543269e-01 | 0.595 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.182899e-01 | 0.497 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.003523e-01 | 0.398 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.808094e-01 | 0.419 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.026511e-01 | 0.395 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.026511e-01 | 0.395 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.003685e-01 | 0.522 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.073481e-01 | 0.512 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.964855e-01 | 0.402 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.846692e-01 | 0.546 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.912671e-01 | 0.536 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.121578e-01 | 0.506 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.036524e-01 | 0.518 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.841788e-01 | 0.415 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.681247e-01 | 0.434 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.570962e-01 | 0.590 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 2.833451e-01 | 0.548 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.349678e-01 | 0.475 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.349678e-01 | 0.475 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.002405e-01 | 0.398 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 3.453473e-01 | 0.462 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.846692e-01 | 0.546 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.161024e-01 | 0.381 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.167190e-01 | 0.380 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.207462e-01 | 0.376 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.235751e-01 | 0.373 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.235751e-01 | 0.373 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.235751e-01 | 0.373 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.235751e-01 | 0.373 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.235751e-01 | 0.373 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.235751e-01 | 0.373 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.235751e-01 | 0.373 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.235751e-01 | 0.373 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.235751e-01 | 0.373 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.235751e-01 | 0.373 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.235751e-01 | 0.373 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.251021e-01 | 0.372 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.268943e-01 | 0.370 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.268943e-01 | 0.370 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.295611e-01 | 0.367 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.308824e-01 | 0.366 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.317501e-01 | 0.365 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.317501e-01 | 0.365 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.317501e-01 | 0.365 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.317501e-01 | 0.365 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 4.317501e-01 | 0.365 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.317501e-01 | 0.365 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.388868e-01 | 0.358 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.406338e-01 | 0.356 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.408111e-01 | 0.356 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.408111e-01 | 0.356 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.471711e-01 | 0.350 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 4.471711e-01 | 0.350 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.471711e-01 | 0.350 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.494502e-01 | 0.347 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.494502e-01 | 0.347 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.494502e-01 | 0.347 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.494502e-01 | 0.347 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.494502e-01 | 0.347 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.494502e-01 | 0.347 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.494502e-01 | 0.347 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.494502e-01 | 0.347 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.494502e-01 | 0.347 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.494502e-01 | 0.347 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.507823e-01 | 0.346 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.507823e-01 | 0.346 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.507823e-01 | 0.346 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.510051e-01 | 0.346 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.589326e-01 | 0.338 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.623540e-01 | 0.335 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.623540e-01 | 0.335 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.623540e-01 | 0.335 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.625734e-01 | 0.335 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.726137e-01 | 0.325 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.741653e-01 | 0.324 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.741653e-01 | 0.324 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.741653e-01 | 0.324 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.741653e-01 | 0.324 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 4.741653e-01 | 0.324 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.741653e-01 | 0.324 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 4.741653e-01 | 0.324 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.741653e-01 | 0.324 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.741653e-01 | 0.324 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.741653e-01 | 0.324 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.764602e-01 | 0.322 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.772893e-01 | 0.321 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.772893e-01 | 0.321 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.772893e-01 | 0.321 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.785494e-01 | 0.320 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.836979e-01 | 0.315 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.850852e-01 | 0.314 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.850852e-01 | 0.314 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.858148e-01 | 0.314 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.905100e-01 | 0.309 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.905310e-01 | 0.309 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.919686e-01 | 0.308 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.919686e-01 | 0.308 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.919686e-01 | 0.308 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.937056e-01 | 0.307 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.977724e-01 | 0.303 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 4.977724e-01 | 0.303 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.977724e-01 | 0.303 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.977724e-01 | 0.303 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.977724e-01 | 0.303 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.977724e-01 | 0.303 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.977724e-01 | 0.303 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.977724e-01 | 0.303 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.977724e-01 | 0.303 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.977724e-01 | 0.303 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.002050e-01 | 0.301 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.011723e-01 | 0.300 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.022723e-01 | 0.299 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.035589e-01 | 0.298 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.038883e-01 | 0.298 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.052336e-01 | 0.297 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.063847e-01 | 0.296 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.063847e-01 | 0.296 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.085608e-01 | 0.294 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.193487e-01 | 0.285 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.194236e-01 | 0.284 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.203210e-01 | 0.284 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.203210e-01 | 0.284 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.203210e-01 | 0.284 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.203210e-01 | 0.284 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.203210e-01 | 0.284 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.203210e-01 | 0.284 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.203210e-01 | 0.284 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.203210e-01 | 0.284 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.203210e-01 | 0.284 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.203210e-01 | 0.284 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.203210e-01 | 0.284 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.203210e-01 | 0.284 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.205317e-01 | 0.284 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.205317e-01 | 0.284 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.241634e-01 | 0.281 | 1 | 1 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.264630e-01 | 0.279 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.276199e-01 | 0.278 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.276199e-01 | 0.278 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.307689e-01 | 0.275 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.307689e-01 | 0.275 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.307689e-01 | 0.275 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.314700e-01 | 0.275 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.322372e-01 | 0.274 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.344048e-01 | 0.272 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.344048e-01 | 0.272 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.344048e-01 | 0.272 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.359426e-01 | 0.271 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.359426e-01 | 0.271 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.392524e-01 | 0.268 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.415662e-01 | 0.266 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.416598e-01 | 0.266 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.418585e-01 | 0.266 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 5.418585e-01 | 0.266 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.418585e-01 | 0.266 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 5.418585e-01 | 0.266 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.418585e-01 | 0.266 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.418585e-01 | 0.266 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 5.418585e-01 | 0.266 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 5.418585e-01 | 0.266 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.418585e-01 | 0.266 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.418585e-01 | 0.266 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.480000e-01 | 0.261 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.492511e-01 | 0.260 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.521574e-01 | 0.258 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.521574e-01 | 0.258 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.604961e-01 | 0.251 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.604961e-01 | 0.251 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.604961e-01 | 0.251 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.604961e-01 | 0.251 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.604961e-01 | 0.251 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.613142e-01 | 0.251 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.613142e-01 | 0.251 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.624303e-01 | 0.250 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.624303e-01 | 0.250 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.624303e-01 | 0.250 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.624303e-01 | 0.250 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.624303e-01 | 0.250 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 5.624303e-01 | 0.250 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.624303e-01 | 0.250 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.624303e-01 | 0.250 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.624303e-01 | 0.250 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.629961e-01 | 0.249 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.629961e-01 | 0.249 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 5.656112e-01 | 0.247 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.685349e-01 | 0.245 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.695330e-01 | 0.244 | 1 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.764975e-01 | 0.239 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.820795e-01 | 0.235 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.820795e-01 | 0.235 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.820795e-01 | 0.235 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.820795e-01 | 0.235 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.820795e-01 | 0.235 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.820795e-01 | 0.235 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.820795e-01 | 0.235 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.820795e-01 | 0.235 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.820795e-01 | 0.235 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.820795e-01 | 0.235 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.820795e-01 | 0.235 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.820795e-01 | 0.235 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.820795e-01 | 0.235 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.820795e-01 | 0.235 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.820795e-01 | 0.235 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.837171e-01 | 0.234 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.843820e-01 | 0.233 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 5.870921e-01 | 0.231 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.870921e-01 | 0.231 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.878564e-01 | 0.231 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.938402e-01 | 0.226 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.938402e-01 | 0.226 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.938402e-01 | 0.226 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.995536e-01 | 0.222 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.995536e-01 | 0.222 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.999095e-01 | 0.222 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.001217e-01 | 0.222 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.008475e-01 | 0.221 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.008475e-01 | 0.221 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.008475e-01 | 0.221 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.008475e-01 | 0.221 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.008475e-01 | 0.221 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.008475e-01 | 0.221 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.008475e-01 | 0.221 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.008475e-01 | 0.221 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.008475e-01 | 0.221 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.008475e-01 | 0.221 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.009571e-01 | 0.221 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.038022e-01 | 0.219 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.071044e-01 | 0.217 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.075494e-01 | 0.216 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.093147e-01 | 0.215 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.117297e-01 | 0.213 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 6.117297e-01 | 0.213 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.117297e-01 | 0.213 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.117297e-01 | 0.213 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.136014e-01 | 0.212 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.136014e-01 | 0.212 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.136014e-01 | 0.212 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.187738e-01 | 0.208 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.187738e-01 | 0.208 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.187738e-01 | 0.208 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 6.187738e-01 | 0.208 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.187738e-01 | 0.208 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.187738e-01 | 0.208 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.225743e-01 | 0.206 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.232361e-01 | 0.205 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 6.232478e-01 | 0.205 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.236210e-01 | 0.205 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.236210e-01 | 0.205 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.327053e-01 | 0.199 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.342013e-01 | 0.198 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.352284e-01 | 0.197 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.352284e-01 | 0.197 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.358960e-01 | 0.197 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.358960e-01 | 0.197 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.358960e-01 | 0.197 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.358960e-01 | 0.197 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.358960e-01 | 0.197 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.358960e-01 | 0.197 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.372510e-01 | 0.196 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.377583e-01 | 0.195 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.392531e-01 | 0.194 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.422655e-01 | 0.192 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 6.435139e-01 | 0.191 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.444561e-01 | 0.191 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.444561e-01 | 0.191 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.444561e-01 | 0.191 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.444561e-01 | 0.191 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.465536e-01 | 0.189 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.465536e-01 | 0.189 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.465536e-01 | 0.189 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 6.465536e-01 | 0.189 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.515709e-01 | 0.186 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.522502e-01 | 0.186 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.522502e-01 | 0.186 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 6.522502e-01 | 0.186 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.522502e-01 | 0.186 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.522502e-01 | 0.186 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.522502e-01 | 0.186 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.522502e-01 | 0.186 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.522502e-01 | 0.186 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.522502e-01 | 0.186 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.522502e-01 | 0.186 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.575983e-01 | 0.182 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.575983e-01 | 0.182 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.580409e-01 | 0.182 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.585948e-01 | 0.181 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.585948e-01 | 0.181 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 6.675528e-01 | 0.176 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.678708e-01 | 0.175 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.678708e-01 | 0.175 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.678708e-01 | 0.175 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.678708e-01 | 0.175 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.678708e-01 | 0.175 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.678708e-01 | 0.175 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.678708e-01 | 0.175 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.678708e-01 | 0.175 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.678708e-01 | 0.175 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.678708e-01 | 0.175 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.683651e-01 | 0.175 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.683651e-01 | 0.175 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.683651e-01 | 0.175 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.683651e-01 | 0.175 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.683651e-01 | 0.175 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.689118e-01 | 0.175 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.738797e-01 | 0.171 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.788564e-01 | 0.168 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.791139e-01 | 0.168 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.791139e-01 | 0.168 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.808109e-01 | 0.167 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.827906e-01 | 0.166 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.827906e-01 | 0.166 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.827906e-01 | 0.166 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.827906e-01 | 0.166 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.827906e-01 | 0.166 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.827906e-01 | 0.166 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.827906e-01 | 0.166 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.857674e-01 | 0.164 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.861398e-01 | 0.164 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.881608e-01 | 0.162 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.917563e-01 | 0.160 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.923272e-01 | 0.160 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.943066e-01 | 0.158 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.970411e-01 | 0.157 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 6.970411e-01 | 0.157 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.970411e-01 | 0.157 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.970411e-01 | 0.157 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.970411e-01 | 0.157 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.970411e-01 | 0.157 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.970411e-01 | 0.157 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.970411e-01 | 0.157 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.970411e-01 | 0.157 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.970411e-01 | 0.157 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.970411e-01 | 0.157 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.973076e-01 | 0.157 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.987929e-01 | 0.156 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.990253e-01 | 0.156 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.990253e-01 | 0.156 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.990253e-01 | 0.156 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.990253e-01 | 0.156 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.990253e-01 | 0.156 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.990253e-01 | 0.156 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.024375e-01 | 0.153 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.024375e-01 | 0.153 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.051643e-01 | 0.152 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.051643e-01 | 0.152 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.064201e-01 | 0.151 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.087097e-01 | 0.150 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 7.087097e-01 | 0.150 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.087097e-01 | 0.150 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.090585e-01 | 0.149 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.106522e-01 | 0.148 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.106522e-01 | 0.148 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.106522e-01 | 0.148 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.106522e-01 | 0.148 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.106522e-01 | 0.148 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.114412e-01 | 0.148 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.114412e-01 | 0.148 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.147867e-01 | 0.146 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.181324e-01 | 0.144 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.182027e-01 | 0.144 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.194839e-01 | 0.143 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.231040e-01 | 0.141 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.236526e-01 | 0.140 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.236526e-01 | 0.140 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.236526e-01 | 0.140 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.236526e-01 | 0.140 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.236526e-01 | 0.140 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.236526e-01 | 0.140 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.236526e-01 | 0.140 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.236526e-01 | 0.140 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.236526e-01 | 0.140 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.236526e-01 | 0.140 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.237112e-01 | 0.140 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.292315e-01 | 0.137 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.333121e-01 | 0.135 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.360696e-01 | 0.133 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.360696e-01 | 0.133 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.360696e-01 | 0.133 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.377285e-01 | 0.132 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.406240e-01 | 0.130 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.448701e-01 | 0.128 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.477758e-01 | 0.126 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.479294e-01 | 0.126 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.479294e-01 | 0.126 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.479294e-01 | 0.126 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.479294e-01 | 0.126 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.479294e-01 | 0.126 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.479294e-01 | 0.126 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.479294e-01 | 0.126 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.479294e-01 | 0.126 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.532869e-01 | 0.123 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.532869e-01 | 0.123 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.547690e-01 | 0.122 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.550570e-01 | 0.122 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.592570e-01 | 0.120 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.592570e-01 | 0.120 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.592570e-01 | 0.120 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.592570e-01 | 0.120 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.592570e-01 | 0.120 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.592570e-01 | 0.120 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.592570e-01 | 0.120 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.592570e-01 | 0.120 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.592570e-01 | 0.120 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.614632e-01 | 0.118 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.614632e-01 | 0.118 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.614632e-01 | 0.118 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.614632e-01 | 0.118 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.614632e-01 | 0.118 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.614632e-01 | 0.118 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.682864e-01 | 0.114 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.693445e-01 | 0.114 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.694037e-01 | 0.114 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.694037e-01 | 0.114 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.694037e-01 | 0.114 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.700762e-01 | 0.113 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.700762e-01 | 0.113 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.700762e-01 | 0.113 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.742705e-01 | 0.111 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.771130e-01 | 0.110 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.785129e-01 | 0.109 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.804098e-01 | 0.108 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.804098e-01 | 0.108 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.804098e-01 | 0.108 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.804098e-01 | 0.108 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.804098e-01 | 0.108 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.804098e-01 | 0.108 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.804098e-01 | 0.108 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.804098e-01 | 0.108 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.804098e-01 | 0.108 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.804098e-01 | 0.108 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.804098e-01 | 0.108 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.804098e-01 | 0.108 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.812524e-01 | 0.107 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.845958e-01 | 0.105 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.845958e-01 | 0.105 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.845958e-01 | 0.105 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.902796e-01 | 0.102 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.902796e-01 | 0.102 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.902796e-01 | 0.102 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.902796e-01 | 0.102 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.902796e-01 | 0.102 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.902796e-01 | 0.102 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.902796e-01 | 0.102 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 7.902796e-01 | 0.102 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.902796e-01 | 0.102 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.902796e-01 | 0.102 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.913754e-01 | 0.102 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.918570e-01 | 0.101 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.958677e-01 | 0.099 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.985156e-01 | 0.098 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.989012e-01 | 0.098 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.994294e-01 | 0.097 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.997063e-01 | 0.097 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.997063e-01 | 0.097 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 7.997063e-01 | 0.097 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.997063e-01 | 0.097 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.997063e-01 | 0.097 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.997063e-01 | 0.097 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.997063e-01 | 0.097 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.997063e-01 | 0.097 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.997063e-01 | 0.097 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.057334e-01 | 0.094 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.087099e-01 | 0.092 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.087099e-01 | 0.092 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.087099e-01 | 0.092 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.087099e-01 | 0.092 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.123584e-01 | 0.090 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.123584e-01 | 0.090 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.163782e-01 | 0.088 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.173092e-01 | 0.088 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.173092e-01 | 0.088 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.173092e-01 | 0.088 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.173092e-01 | 0.088 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.173092e-01 | 0.088 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.187809e-01 | 0.087 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.187809e-01 | 0.087 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.212710e-01 | 0.086 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.250058e-01 | 0.084 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 8.250058e-01 | 0.084 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.250058e-01 | 0.084 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.296807e-01 | 0.081 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.310378e-01 | 0.080 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.310378e-01 | 0.080 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.320957e-01 | 0.080 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.333670e-01 | 0.079 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.333670e-01 | 0.079 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.333670e-01 | 0.079 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.333670e-01 | 0.079 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.383989e-01 | 0.077 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.408593e-01 | 0.075 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.408593e-01 | 0.075 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.408593e-01 | 0.075 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.408593e-01 | 0.075 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.423462e-01 | 0.075 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 8.425423e-01 | 0.074 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.480151e-01 | 0.072 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.480151e-01 | 0.072 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.480151e-01 | 0.072 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.480151e-01 | 0.072 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.480151e-01 | 0.072 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.480151e-01 | 0.072 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.480151e-01 | 0.072 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 8.512436e-01 | 0.070 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.533318e-01 | 0.069 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.548255e-01 | 0.068 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.548496e-01 | 0.068 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.548496e-01 | 0.068 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.548496e-01 | 0.068 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.548496e-01 | 0.068 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.584699e-01 | 0.066 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.609078e-01 | 0.065 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.613772e-01 | 0.065 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.613772e-01 | 0.065 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.613772e-01 | 0.065 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.613772e-01 | 0.065 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.613772e-01 | 0.065 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.613772e-01 | 0.065 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.633554e-01 | 0.064 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.643294e-01 | 0.063 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.664866e-01 | 0.062 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.676115e-01 | 0.062 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.676115e-01 | 0.062 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.676115e-01 | 0.062 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.684609e-01 | 0.061 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.724810e-01 | 0.059 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.735659e-01 | 0.059 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.735659e-01 | 0.059 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.735659e-01 | 0.059 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.735659e-01 | 0.059 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.735659e-01 | 0.059 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.738629e-01 | 0.059 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.738629e-01 | 0.059 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.772144e-01 | 0.057 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.792528e-01 | 0.056 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.792528e-01 | 0.056 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.792528e-01 | 0.056 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.792528e-01 | 0.056 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.792528e-01 | 0.056 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.792528e-01 | 0.056 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.817729e-01 | 0.055 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.817729e-01 | 0.055 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.817729e-01 | 0.055 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.817729e-01 | 0.055 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 8.829694e-01 | 0.054 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.846842e-01 | 0.053 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.846842e-01 | 0.053 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.846842e-01 | 0.053 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.846842e-01 | 0.053 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.846842e-01 | 0.053 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.898717e-01 | 0.051 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.898717e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.900598e-01 | 0.051 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.900598e-01 | 0.051 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.925643e-01 | 0.049 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.939982e-01 | 0.049 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.948261e-01 | 0.048 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.948261e-01 | 0.048 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.948261e-01 | 0.048 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.948261e-01 | 0.048 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.948261e-01 | 0.048 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 8.948261e-01 | 0.048 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.976968e-01 | 0.047 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.978050e-01 | 0.047 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.995578e-01 | 0.046 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.014843e-01 | 0.045 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.040283e-01 | 0.044 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.040770e-01 | 0.044 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.041945e-01 | 0.044 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.050396e-01 | 0.043 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.050396e-01 | 0.043 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.050396e-01 | 0.043 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.050396e-01 | 0.043 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.077510e-01 | 0.042 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.083931e-01 | 0.042 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.083931e-01 | 0.042 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.100037e-01 | 0.041 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.125153e-01 | 0.040 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.125153e-01 | 0.040 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.125153e-01 | 0.040 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.149990e-01 | 0.039 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.156397e-01 | 0.038 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.164522e-01 | 0.038 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.164522e-01 | 0.038 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.164522e-01 | 0.038 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.164522e-01 | 0.038 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.183355e-01 | 0.037 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.202122e-01 | 0.036 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.202122e-01 | 0.036 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.202122e-01 | 0.036 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.210848e-01 | 0.036 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.210892e-01 | 0.036 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.234928e-01 | 0.035 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.238031e-01 | 0.034 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.238031e-01 | 0.034 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.238031e-01 | 0.034 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.239716e-01 | 0.034 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.253341e-01 | 0.034 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.272327e-01 | 0.033 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.272327e-01 | 0.033 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.272327e-01 | 0.033 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.279073e-01 | 0.032 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.290041e-01 | 0.032 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.294492e-01 | 0.032 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.305081e-01 | 0.031 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.336363e-01 | 0.030 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.336363e-01 | 0.030 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.336363e-01 | 0.030 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.366238e-01 | 0.028 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.366238e-01 | 0.028 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.366238e-01 | 0.028 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.369709e-01 | 0.028 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.391597e-01 | 0.027 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.394770e-01 | 0.027 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.415561e-01 | 0.026 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.415561e-01 | 0.026 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.422019e-01 | 0.026 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.444741e-01 | 0.025 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.448043e-01 | 0.025 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.472897e-01 | 0.024 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.472897e-01 | 0.024 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.472897e-01 | 0.024 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.478439e-01 | 0.023 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.478439e-01 | 0.023 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.493613e-01 | 0.023 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.496633e-01 | 0.022 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.497927e-01 | 0.022 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.519302e-01 | 0.021 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.519302e-01 | 0.021 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.538513e-01 | 0.021 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.540951e-01 | 0.020 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.561626e-01 | 0.019 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.561626e-01 | 0.019 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.561626e-01 | 0.019 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.561626e-01 | 0.019 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.562639e-01 | 0.019 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.581371e-01 | 0.019 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.600229e-01 | 0.018 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.605233e-01 | 0.017 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.618237e-01 | 0.017 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.635436e-01 | 0.016 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.635436e-01 | 0.016 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.658134e-01 | 0.015 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.659256e-01 | 0.015 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.670436e-01 | 0.015 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.682526e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.682526e-01 | 0.014 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.682526e-01 | 0.014 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.696832e-01 | 0.013 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.696832e-01 | 0.013 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.696832e-01 | 0.013 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.723541e-01 | 0.012 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.723541e-01 | 0.012 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.736001e-01 | 0.012 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.736001e-01 | 0.012 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.736001e-01 | 0.012 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.736001e-01 | 0.012 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.747900e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.770116e-01 | 0.010 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.776493e-01 | 0.010 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.780479e-01 | 0.010 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.780479e-01 | 0.010 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.780479e-01 | 0.010 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.808852e-01 | 0.008 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.817472e-01 | 0.008 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.817472e-01 | 0.008 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.825703e-01 | 0.008 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.831236e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.831236e-01 | 0.007 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.833563e-01 | 0.007 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.848237e-01 | 0.007 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.855083e-01 | 0.006 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.856046e-01 | 0.006 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.867083e-01 | 0.006 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.873823e-01 | 0.006 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.910206e-01 | 0.004 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.911020e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.916730e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.916730e-01 | 0.004 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.922080e-01 | 0.003 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.924367e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.927506e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.933905e-01 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.939739e-01 | 0.003 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.947541e-01 | 0.002 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.952173e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.957192e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.962044e-01 | 0.002 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.965515e-01 | 0.002 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.972541e-01 | 0.001 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.973645e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.983495e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.986736e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.986906e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.987779e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.991865e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.992133e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.993176e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.994431e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.994571e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.995614e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.995694e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.995725e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998043e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998070e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998744e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.998839e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998879e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999319e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999488e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999615e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999849e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999892e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999929e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999937e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| M Phase | R-HSA-68886 | 4.522662e-10 | 9.345 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.231109e-09 | 8.910 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.003600e-09 | 8.698 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.003034e-08 | 7.698 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.958379e-08 | 7.529 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.465924e-08 | 7.460 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.517275e-08 | 7.258 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.115459e-07 | 6.953 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.900653e-07 | 6.721 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.594282e-07 | 6.586 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.665045e-07 | 6.574 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.680692e-07 | 6.572 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.900742e-07 | 6.409 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.888840e-07 | 6.162 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.130428e-07 | 6.090 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.452000e-07 | 6.073 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.452000e-07 | 6.073 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.647083e-06 | 5.783 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.634538e-06 | 5.787 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.112935e-06 | 5.675 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.272232e-06 | 5.644 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.431416e-06 | 5.614 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.724432e-06 | 5.565 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.162787e-06 | 5.500 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.220831e-06 | 5.492 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.280586e-06 | 5.484 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.959601e-06 | 5.402 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.278642e-06 | 5.369 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.981580e-06 | 5.303 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.621095e-06 | 5.335 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.262300e-06 | 5.083 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.596178e-06 | 5.018 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.031187e-05 | 4.987 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.031187e-05 | 4.987 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.121312e-05 | 4.950 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.136730e-05 | 4.944 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.358906e-05 | 4.867 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.358906e-05 | 4.867 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.293350e-05 | 4.888 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.365950e-05 | 4.865 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.463268e-05 | 4.835 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.547508e-05 | 4.810 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.787385e-05 | 4.748 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.798239e-05 | 4.745 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.972056e-05 | 4.705 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.164192e-05 | 4.665 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.009741e-05 | 4.697 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.140664e-05 | 4.669 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.164192e-05 | 4.665 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.476160e-05 | 4.606 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.514960e-05 | 4.599 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.514960e-05 | 4.599 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.400964e-05 | 4.468 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.400964e-05 | 4.468 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.319544e-05 | 4.479 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.319544e-05 | 4.479 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.190541e-05 | 4.496 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.182089e-05 | 4.497 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.553618e-05 | 4.449 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.590823e-05 | 4.445 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.644699e-05 | 4.438 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.920066e-05 | 4.407 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.030149e-05 | 4.395 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.618068e-05 | 4.336 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.897247e-05 | 4.310 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.687903e-05 | 4.245 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.112846e-05 | 4.214 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.112846e-05 | 4.214 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.347125e-05 | 4.197 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.012899e-05 | 4.154 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.020052e-05 | 4.154 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.945601e-05 | 4.100 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.952025e-05 | 4.100 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.531171e-05 | 4.069 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.975021e-05 | 4.047 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.009589e-04 | 3.996 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.009589e-04 | 3.996 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.106523e-04 | 3.956 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.138428e-04 | 3.944 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.196990e-04 | 3.922 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.138558e-04 | 3.944 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.167869e-04 | 3.933 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.368285e-04 | 3.864 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.368285e-04 | 3.864 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.500464e-04 | 3.824 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.518236e-04 | 3.819 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.591423e-04 | 3.798 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.591423e-04 | 3.798 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.883111e-04 | 3.725 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.915666e-04 | 3.718 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.997769e-04 | 3.699 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.168270e-04 | 3.664 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.217965e-04 | 3.654 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.418117e-04 | 3.617 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.347304e-04 | 3.629 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.355124e-04 | 3.628 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.708743e-04 | 3.567 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.941253e-04 | 3.531 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.008360e-04 | 3.522 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.036879e-04 | 3.518 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.039351e-04 | 3.517 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.174382e-04 | 3.498 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.504477e-04 | 3.455 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.635066e-04 | 3.439 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.635066e-04 | 3.439 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.236387e-04 | 3.373 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.236387e-04 | 3.373 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.075969e-04 | 3.294 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.075341e-04 | 3.295 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.264259e-04 | 3.279 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.429820e-04 | 3.265 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.353143e-04 | 3.271 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.441165e-04 | 3.264 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.634111e-04 | 3.249 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.697465e-04 | 3.244 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.729177e-04 | 3.242 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.386572e-04 | 3.195 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.568747e-04 | 3.183 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.940448e-04 | 3.159 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.105352e-04 | 3.148 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.050095e-04 | 3.094 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.050095e-04 | 3.094 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 8.050095e-04 | 3.094 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.050095e-04 | 3.094 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.050095e-04 | 3.094 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.050095e-04 | 3.094 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.050095e-04 | 3.094 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.050095e-04 | 3.094 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.050095e-04 | 3.094 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.050095e-04 | 3.094 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.050095e-04 | 3.094 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.050095e-04 | 3.094 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.143851e-04 | 3.089 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.585950e-04 | 3.066 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.737813e-04 | 3.059 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.737813e-04 | 3.059 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.011438e-04 | 3.045 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.784235e-04 | 3.009 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.155039e-03 | 2.937 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.145303e-03 | 2.941 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.068789e-03 | 2.971 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.244233e-03 | 2.905 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.373004e-03 | 2.862 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.482315e-03 | 2.829 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.521707e-03 | 2.818 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.557953e-03 | 2.807 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.564376e-03 | 2.806 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.569177e-03 | 2.804 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.668874e-03 | 2.778 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.763454e-03 | 2.754 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.763454e-03 | 2.754 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.763454e-03 | 2.754 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.874897e-03 | 2.727 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.923245e-03 | 2.716 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.995602e-03 | 2.700 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.295236e-03 | 2.639 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.295389e-03 | 2.639 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.233865e-03 | 2.651 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.072585e-03 | 2.683 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.445656e-03 | 2.612 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.490797e-03 | 2.604 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.527310e-03 | 2.597 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.532325e-03 | 2.596 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.532325e-03 | 2.596 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.625553e-03 | 2.581 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.642784e-03 | 2.578 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.646648e-03 | 2.577 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.714863e-03 | 2.566 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.817249e-03 | 2.550 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.817249e-03 | 2.550 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.853411e-03 | 2.545 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.853411e-03 | 2.545 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.867445e-03 | 2.543 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.014578e-03 | 2.521 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.682372e-03 | 2.434 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.175609e-03 | 2.498 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.175609e-03 | 2.498 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.175609e-03 | 2.498 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.175609e-03 | 2.498 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.191952e-03 | 2.496 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.446590e-03 | 2.463 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.324272e-03 | 2.478 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.472589e-03 | 2.459 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.706309e-03 | 2.431 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.775091e-03 | 2.423 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.783551e-03 | 2.422 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.853402e-03 | 2.414 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.132827e-03 | 2.384 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.179544e-03 | 2.379 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.179544e-03 | 2.379 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.370518e-03 | 2.359 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.450650e-03 | 2.352 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.471434e-03 | 2.350 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.471434e-03 | 2.350 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.599676e-03 | 2.337 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.663057e-03 | 2.331 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.728014e-03 | 2.325 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.744333e-03 | 2.324 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.961286e-03 | 2.304 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.961286e-03 | 2.304 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.328894e-03 | 2.273 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.347349e-03 | 2.272 | 1 | 1 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.469471e-03 | 2.262 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.499177e-03 | 2.260 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.653075e-03 | 2.248 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.338401e-03 | 2.198 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.424143e-03 | 2.192 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.682722e-03 | 2.114 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.485795e-03 | 2.188 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.738467e-03 | 2.111 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.738467e-03 | 2.111 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.014949e-03 | 2.154 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.138681e-03 | 2.146 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.792416e-03 | 2.108 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.047502e-03 | 2.094 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.272558e-03 | 2.082 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.449683e-03 | 2.073 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.485835e-03 | 2.071 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.875962e-03 | 2.052 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.007065e-02 | 1.997 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.018463e-02 | 1.992 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.018463e-02 | 1.992 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.032113e-02 | 1.986 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.034922e-02 | 1.985 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.060787e-02 | 1.974 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.060787e-02 | 1.974 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.064865e-02 | 1.973 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.094076e-02 | 1.961 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.111345e-02 | 1.954 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.145978e-02 | 1.941 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.181192e-02 | 1.928 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.186521e-02 | 1.926 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.195048e-02 | 1.923 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.233778e-02 | 1.909 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.259921e-02 | 1.900 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.283367e-02 | 1.892 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.333772e-02 | 1.875 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.333772e-02 | 1.875 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.348733e-02 | 1.870 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.471579e-02 | 1.832 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.484369e-02 | 1.828 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.500218e-02 | 1.824 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.504191e-02 | 1.823 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.660200e-02 | 1.780 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.870294e-02 | 1.728 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.599516e-02 | 1.796 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.937863e-02 | 1.713 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.676783e-02 | 1.776 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.995548e-02 | 1.700 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.765791e-02 | 1.753 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.676783e-02 | 1.776 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.923958e-02 | 1.716 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.995548e-02 | 1.700 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.736764e-02 | 1.760 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.003438e-02 | 1.698 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.024072e-02 | 1.694 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.064555e-02 | 1.685 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.064555e-02 | 1.685 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.064555e-02 | 1.685 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.076132e-02 | 1.683 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.109611e-02 | 1.676 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.109611e-02 | 1.676 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.130002e-02 | 1.672 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.143805e-02 | 1.669 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.144546e-02 | 1.669 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.186449e-02 | 1.660 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.274934e-02 | 1.643 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.309409e-02 | 1.636 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.342327e-02 | 1.630 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.421574e-02 | 1.616 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.537826e-02 | 1.596 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.603157e-02 | 1.584 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.603157e-02 | 1.584 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.614117e-02 | 1.583 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.625887e-02 | 1.581 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.638863e-02 | 1.579 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.789280e-02 | 1.555 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.813534e-02 | 1.551 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.827935e-02 | 1.549 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.833481e-02 | 1.548 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.851505e-02 | 1.545 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.926274e-02 | 1.534 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.944203e-02 | 1.531 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.944203e-02 | 1.531 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.951604e-02 | 1.530 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.975082e-02 | 1.527 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.082775e-02 | 1.511 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.101053e-02 | 1.508 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.101053e-02 | 1.508 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.134318e-02 | 1.504 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.134318e-02 | 1.504 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.145162e-02 | 1.502 | 1 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.903847e-02 | 1.409 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.497447e-02 | 1.456 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.497447e-02 | 1.456 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.497447e-02 | 1.456 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.497447e-02 | 1.456 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.497447e-02 | 1.456 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.702147e-02 | 1.432 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.398799e-02 | 1.469 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.398799e-02 | 1.469 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.734919e-02 | 1.428 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.624805e-02 | 1.441 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.624805e-02 | 1.441 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.437376e-02 | 1.464 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.497447e-02 | 1.456 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.903847e-02 | 1.409 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.713690e-02 | 1.430 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.015447e-02 | 1.396 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.580275e-02 | 1.446 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.752769e-02 | 1.426 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.020408e-02 | 1.396 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.465140e-02 | 1.460 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.486122e-02 | 1.458 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.066265e-02 | 1.391 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.026806e-02 | 1.395 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.207743e-02 | 1.376 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.549650e-02 | 1.450 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.369363e-02 | 1.360 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.395570e-02 | 1.357 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.562059e-02 | 1.341 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.571450e-02 | 1.340 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.666993e-02 | 1.331 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.897021e-02 | 1.310 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.897021e-02 | 1.310 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.920459e-02 | 1.308 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.955257e-02 | 1.305 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.955257e-02 | 1.305 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.955257e-02 | 1.305 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.020546e-02 | 1.299 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.020546e-02 | 1.299 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.020546e-02 | 1.299 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.030260e-02 | 1.298 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.030260e-02 | 1.298 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.134417e-02 | 1.290 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.147657e-02 | 1.288 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.151580e-02 | 1.288 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.156296e-02 | 1.288 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.183608e-02 | 1.285 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.325483e-02 | 1.274 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.325483e-02 | 1.274 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 5.325483e-02 | 1.274 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.447270e-02 | 1.264 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.462495e-02 | 1.263 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.550172e-02 | 1.256 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.672654e-02 | 1.246 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.693523e-02 | 1.245 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.970341e-02 | 1.224 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.970341e-02 | 1.224 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.975092e-02 | 1.224 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.982037e-02 | 1.223 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.018584e-02 | 1.221 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.095270e-02 | 1.215 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.095498e-02 | 1.215 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.095498e-02 | 1.215 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.340679e-02 | 1.198 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.408128e-02 | 1.193 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.408128e-02 | 1.193 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.426179e-02 | 1.192 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.433898e-02 | 1.192 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.463851e-02 | 1.072 | 0 | 0 |
| MGMT-mediated DNA damage reversal | R-HSA-5657655 | 8.463851e-02 | 1.072 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.463851e-02 | 1.072 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.463851e-02 | 1.072 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.463851e-02 | 1.072 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.463851e-02 | 1.072 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 7.314942e-02 | 1.136 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.314942e-02 | 1.136 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.314942e-02 | 1.136 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.314942e-02 | 1.136 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.314942e-02 | 1.136 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.604625e-02 | 1.065 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 9.956209e-02 | 1.002 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.956209e-02 | 1.002 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.331460e-02 | 1.079 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.331460e-02 | 1.079 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 9.175325e-02 | 1.037 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.154221e-02 | 1.145 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.746519e-02 | 1.111 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.362540e-02 | 1.078 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.362540e-02 | 1.078 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.663732e-02 | 1.015 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.863461e-02 | 1.163 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.863461e-02 | 1.163 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.863461e-02 | 1.163 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.826324e-02 | 1.106 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.857743e-02 | 1.053 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.007024e-02 | 1.154 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.574989e-02 | 1.067 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.544585e-02 | 1.020 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.663732e-02 | 1.015 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.751559e-02 | 1.171 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.331460e-02 | 1.079 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.604625e-02 | 1.065 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 9.956209e-02 | 1.002 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.610991e-02 | 1.119 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.610991e-02 | 1.119 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.057691e-02 | 1.043 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.751559e-02 | 1.171 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.331460e-02 | 1.079 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.523014e-02 | 1.124 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.175325e-02 | 1.037 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.305143e-02 | 1.136 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.314942e-02 | 1.136 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.956209e-02 | 1.002 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.523014e-02 | 1.124 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.331460e-02 | 1.079 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.663732e-02 | 1.015 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.336237e-02 | 1.135 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.815460e-02 | 1.008 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.336045e-02 | 1.030 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 7.314942e-02 | 1.136 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.956209e-02 | 1.002 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.398661e-02 | 1.027 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.671028e-02 | 1.015 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.125250e-02 | 1.147 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.673475e-02 | 1.014 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.333557e-02 | 1.079 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.175325e-02 | 1.037 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.911625e-02 | 1.004 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.305143e-02 | 1.136 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.955445e-02 | 1.158 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.314942e-02 | 1.136 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.604625e-02 | 1.065 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 8.604625e-02 | 1.065 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 9.956209e-02 | 1.002 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 9.663732e-02 | 1.015 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.912156e-02 | 1.050 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.751559e-02 | 1.171 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.154221e-02 | 1.145 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.746519e-02 | 1.111 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.573179e-02 | 1.019 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.647165e-02 | 1.177 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.005297e-01 | 0.998 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.005297e-01 | 0.998 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.005297e-01 | 0.998 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.005297e-01 | 0.998 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.034778e-01 | 0.985 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.052968e-01 | 0.978 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 1.096271e-01 | 0.960 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 1.096271e-01 | 0.960 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.096271e-01 | 0.960 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.105332e-01 | 0.957 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.105332e-01 | 0.957 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.136194e-01 | 0.945 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.136194e-01 | 0.945 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.136194e-01 | 0.945 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.136194e-01 | 0.945 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.141271e-01 | 0.943 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.177968e-01 | 0.929 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.177968e-01 | 0.929 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.177968e-01 | 0.929 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.190281e-01 | 0.924 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.190281e-01 | 0.924 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.220688e-01 | 0.913 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.232032e-01 | 0.909 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.232585e-01 | 0.909 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.242358e-01 | 0.906 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.242358e-01 | 0.906 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 1.242358e-01 | 0.906 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 1.242358e-01 | 0.906 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.242358e-01 | 0.906 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.242358e-01 | 0.906 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.242358e-01 | 0.906 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.242358e-01 | 0.906 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.242358e-01 | 0.906 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.242358e-01 | 0.906 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.271173e-01 | 0.896 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.281463e-01 | 0.892 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.287153e-01 | 0.890 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.287153e-01 | 0.890 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.293066e-01 | 0.888 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.298004e-01 | 0.887 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.298004e-01 | 0.887 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.298004e-01 | 0.887 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.322525e-01 | 0.879 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.329211e-01 | 0.876 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.329211e-01 | 0.876 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.352068e-01 | 0.869 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.362985e-01 | 0.866 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.362985e-01 | 0.866 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.370797e-01 | 0.863 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.386709e-01 | 0.858 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.386709e-01 | 0.858 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.386709e-01 | 0.858 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.407671e-01 | 0.851 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.409755e-01 | 0.851 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.416319e-01 | 0.849 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.430760e-01 | 0.844 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.430760e-01 | 0.844 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.430760e-01 | 0.844 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.430760e-01 | 0.844 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.468562e-01 | 0.833 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.475646e-01 | 0.831 | 0 | 0 |
| Translation | R-HSA-72766 | 1.479037e-01 | 0.830 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.621225e-01 | 0.790 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 1.983724e-01 | 0.703 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.330561e-01 | 0.633 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.330561e-01 | 0.633 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.330561e-01 | 0.633 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.662411e-01 | 0.575 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.583465e-01 | 0.800 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.739007e-01 | 0.760 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.896854e-01 | 0.722 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.488772e-01 | 0.827 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.217545e-01 | 0.654 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.217545e-01 | 0.654 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.217545e-01 | 0.654 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 1.593163e-01 | 0.798 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 1.593163e-01 | 0.798 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 1.593163e-01 | 0.798 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.593163e-01 | 0.798 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.699707e-01 | 0.770 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.542063e-01 | 0.595 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.542063e-01 | 0.595 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.542063e-01 | 0.595 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.704820e-01 | 0.568 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.030516e-01 | 0.692 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.143945e-01 | 0.669 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.184808e-01 | 0.661 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.965842e-01 | 0.528 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.561240e-01 | 0.592 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.851497e-01 | 0.545 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.582647e-01 | 0.801 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.851497e-01 | 0.545 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.630988e-01 | 0.580 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.143945e-01 | 0.669 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.854999e-01 | 0.732 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.093132e-01 | 0.679 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.277540e-01 | 0.643 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.896854e-01 | 0.722 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.569890e-01 | 0.804 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.374556e-01 | 0.624 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.965842e-01 | 0.528 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.330561e-01 | 0.633 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.583465e-01 | 0.800 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.056517e-01 | 0.687 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 1.488772e-01 | 0.827 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.258678e-01 | 0.646 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.657370e-01 | 0.576 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.217545e-01 | 0.654 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.808229e-01 | 0.743 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.609129e-01 | 0.584 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.662411e-01 | 0.575 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.217545e-01 | 0.654 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.217545e-01 | 0.654 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 1.699707e-01 | 0.770 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.704820e-01 | 0.568 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.825265e-01 | 0.739 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.491423e-01 | 0.604 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.727528e-01 | 0.564 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 2.727528e-01 | 0.564 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 1.983724e-01 | 0.703 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 2.662411e-01 | 0.575 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.896854e-01 | 0.722 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.143945e-01 | 0.669 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.867469e-01 | 0.543 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.739007e-01 | 0.760 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.217545e-01 | 0.654 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.621225e-01 | 0.790 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 1.621225e-01 | 0.790 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.983724e-01 | 0.703 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.330561e-01 | 0.633 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.704820e-01 | 0.568 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.704820e-01 | 0.568 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.569890e-01 | 0.804 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.569890e-01 | 0.804 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.093132e-01 | 0.679 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.528464e-01 | 0.816 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.371244e-01 | 0.625 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.704820e-01 | 0.568 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.488772e-01 | 0.827 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 2.374556e-01 | 0.624 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.137422e-01 | 0.670 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.277540e-01 | 0.643 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.986726e-01 | 0.702 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.399261e-01 | 0.620 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 2.143945e-01 | 0.669 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.870475e-01 | 0.728 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.621225e-01 | 0.790 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.621225e-01 | 0.790 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.056517e-01 | 0.687 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.542063e-01 | 0.595 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.491423e-01 | 0.604 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.727528e-01 | 0.564 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.688386e-01 | 0.773 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.113599e-01 | 0.675 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.379521e-01 | 0.624 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.090023e-01 | 0.680 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.867469e-01 | 0.543 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.947220e-01 | 0.531 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.056517e-01 | 0.687 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.808229e-01 | 0.743 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.833637e-01 | 0.548 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.636279e-01 | 0.579 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.512935e-01 | 0.600 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.245896e-01 | 0.649 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.056517e-01 | 0.687 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.491423e-01 | 0.604 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.240946e-01 | 0.650 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.696188e-01 | 0.771 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.322013e-01 | 0.634 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.400756e-01 | 0.620 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.621225e-01 | 0.790 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.662411e-01 | 0.575 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.739007e-01 | 0.760 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.699707e-01 | 0.770 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.534974e-01 | 0.814 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.859101e-01 | 0.731 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.800554e-01 | 0.553 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.704820e-01 | 0.568 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.846477e-01 | 0.546 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.371244e-01 | 0.625 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.056517e-01 | 0.687 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 1.918555e-01 | 0.717 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 2.609129e-01 | 0.584 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.609129e-01 | 0.584 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.708963e-01 | 0.767 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.609129e-01 | 0.584 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.184808e-01 | 0.661 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.422538e-01 | 0.616 | 1 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.808229e-01 | 0.743 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.566237e-01 | 0.805 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.374556e-01 | 0.624 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 2.030516e-01 | 0.692 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.704820e-01 | 0.568 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 1.583465e-01 | 0.800 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.970789e-01 | 0.527 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.979922e-01 | 0.526 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.979922e-01 | 0.526 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.979922e-01 | 0.526 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.979922e-01 | 0.526 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 2.979922e-01 | 0.526 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.979922e-01 | 0.526 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.979922e-01 | 0.526 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 2.979922e-01 | 0.526 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 2.979922e-01 | 0.526 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.982912e-01 | 0.525 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.018391e-01 | 0.520 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.029716e-01 | 0.519 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.029716e-01 | 0.519 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.036959e-01 | 0.518 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.047596e-01 | 0.516 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.047596e-01 | 0.516 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.109338e-01 | 0.507 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.146196e-01 | 0.502 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.191291e-01 | 0.496 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.191291e-01 | 0.496 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.191291e-01 | 0.496 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.191291e-01 | 0.496 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.191291e-01 | 0.496 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.205293e-01 | 0.494 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.277828e-01 | 0.484 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 3.283712e-01 | 0.484 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.283712e-01 | 0.484 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.283712e-01 | 0.484 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.283712e-01 | 0.484 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.283712e-01 | 0.484 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.325132e-01 | 0.478 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.325132e-01 | 0.478 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 3.325431e-01 | 0.478 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.325431e-01 | 0.478 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.351948e-01 | 0.475 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.351948e-01 | 0.475 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.380691e-01 | 0.471 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.443335e-01 | 0.463 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.444891e-01 | 0.463 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.444891e-01 | 0.463 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.444891e-01 | 0.463 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.444891e-01 | 0.463 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.445396e-01 | 0.463 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.498105e-01 | 0.456 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.511467e-01 | 0.455 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.511467e-01 | 0.455 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.511467e-01 | 0.455 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.511467e-01 | 0.455 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.542596e-01 | 0.451 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.564458e-01 | 0.448 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.564458e-01 | 0.448 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.564458e-01 | 0.448 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.564458e-01 | 0.448 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 3.574374e-01 | 0.447 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.574374e-01 | 0.447 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.574374e-01 | 0.447 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.574374e-01 | 0.447 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.574374e-01 | 0.447 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.574374e-01 | 0.447 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.574374e-01 | 0.447 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.641854e-01 | 0.439 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 3.669644e-01 | 0.435 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.669644e-01 | 0.435 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.683728e-01 | 0.434 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.683728e-01 | 0.434 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.696131e-01 | 0.432 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.706897e-01 | 0.431 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.741045e-01 | 0.427 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.756087e-01 | 0.425 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.768713e-01 | 0.424 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 3.802599e-01 | 0.420 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.802599e-01 | 0.420 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.802599e-01 | 0.420 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.802599e-01 | 0.420 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.826297e-01 | 0.417 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.826297e-01 | 0.417 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.826297e-01 | 0.417 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.844465e-01 | 0.415 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.852473e-01 | 0.414 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.852473e-01 | 0.414 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.852473e-01 | 0.414 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.852473e-01 | 0.414 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.852473e-01 | 0.414 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.852473e-01 | 0.414 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.859560e-01 | 0.413 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.920976e-01 | 0.407 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.991927e-01 | 0.399 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.037607e-01 | 0.394 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.038769e-01 | 0.394 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.038769e-01 | 0.394 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.038769e-01 | 0.394 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.038769e-01 | 0.394 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.103773e-01 | 0.387 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.118552e-01 | 0.385 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.118552e-01 | 0.385 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.118552e-01 | 0.385 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.118552e-01 | 0.385 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.118552e-01 | 0.385 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.118552e-01 | 0.385 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.118552e-01 | 0.385 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.134392e-01 | 0.384 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.134392e-01 | 0.384 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.134392e-01 | 0.384 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.134392e-01 | 0.384 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.155892e-01 | 0.381 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.155892e-01 | 0.381 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.155892e-01 | 0.381 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.155892e-01 | 0.381 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.155892e-01 | 0.381 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.155892e-01 | 0.381 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.155892e-01 | 0.381 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.189905e-01 | 0.378 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.222686e-01 | 0.374 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.233900e-01 | 0.373 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.243419e-01 | 0.372 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.268765e-01 | 0.370 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.272263e-01 | 0.369 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.272263e-01 | 0.369 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.285556e-01 | 0.368 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.285556e-01 | 0.368 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.285556e-01 | 0.368 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.285556e-01 | 0.368 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.300134e-01 | 0.367 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.373131e-01 | 0.359 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.373131e-01 | 0.359 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.373131e-01 | 0.359 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.373131e-01 | 0.359 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.373131e-01 | 0.359 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.373131e-01 | 0.359 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.387807e-01 | 0.358 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.387807e-01 | 0.358 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.434638e-01 | 0.353 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.434638e-01 | 0.353 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.434638e-01 | 0.353 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.434638e-01 | 0.353 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.520340e-01 | 0.345 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.525161e-01 | 0.344 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.581534e-01 | 0.339 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.616129e-01 | 0.336 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.616627e-01 | 0.336 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.616704e-01 | 0.336 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.616704e-01 | 0.336 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.616704e-01 | 0.336 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.616704e-01 | 0.336 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.616704e-01 | 0.336 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.616704e-01 | 0.336 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.616704e-01 | 0.336 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.616704e-01 | 0.336 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 4.616704e-01 | 0.336 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.616704e-01 | 0.336 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.616704e-01 | 0.336 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.616704e-01 | 0.336 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.616704e-01 | 0.336 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.621208e-01 | 0.335 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.621208e-01 | 0.335 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.716661e-01 | 0.326 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.726155e-01 | 0.325 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.726155e-01 | 0.325 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.726155e-01 | 0.325 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.726155e-01 | 0.325 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.840338e-01 | 0.315 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.840338e-01 | 0.315 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.849179e-01 | 0.314 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.849749e-01 | 0.314 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.849749e-01 | 0.314 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.849749e-01 | 0.314 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.849749e-01 | 0.314 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.849749e-01 | 0.314 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.849749e-01 | 0.314 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.849749e-01 | 0.314 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.849749e-01 | 0.314 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.849749e-01 | 0.314 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.849749e-01 | 0.314 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.868422e-01 | 0.313 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.868422e-01 | 0.313 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.950757e-01 | 0.305 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.950757e-01 | 0.305 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.950757e-01 | 0.305 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.968497e-01 | 0.304 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.999046e-01 | 0.301 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.008269e-01 | 0.300 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.059983e-01 | 0.296 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.072718e-01 | 0.295 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.072718e-01 | 0.295 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.072718e-01 | 0.295 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.072718e-01 | 0.295 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.072718e-01 | 0.295 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.072718e-01 | 0.295 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.072718e-01 | 0.295 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.072718e-01 | 0.295 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.072718e-01 | 0.295 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.072718e-01 | 0.295 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.072718e-01 | 0.295 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.072718e-01 | 0.295 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.072718e-01 | 0.295 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.072718e-01 | 0.295 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 5.115672e-01 | 0.291 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.145638e-01 | 0.289 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.145638e-01 | 0.289 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.145638e-01 | 0.289 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.145638e-01 | 0.289 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.145638e-01 | 0.289 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.145638e-01 | 0.289 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.167970e-01 | 0.287 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.197053e-01 | 0.284 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.274676e-01 | 0.278 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.277854e-01 | 0.278 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.277854e-01 | 0.278 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.277854e-01 | 0.278 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.280481e-01 | 0.277 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.280481e-01 | 0.277 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.286047e-01 | 0.277 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.286047e-01 | 0.277 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.286047e-01 | 0.277 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.286047e-01 | 0.277 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.286047e-01 | 0.277 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.286047e-01 | 0.277 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.286047e-01 | 0.277 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.286047e-01 | 0.277 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.355614e-01 | 0.271 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.355614e-01 | 0.271 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 5.412761e-01 | 0.267 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.412761e-01 | 0.267 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.412761e-01 | 0.267 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.412761e-01 | 0.267 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.490152e-01 | 0.260 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.490152e-01 | 0.260 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.490152e-01 | 0.260 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.490152e-01 | 0.260 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.490152e-01 | 0.260 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.490152e-01 | 0.260 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.499991e-01 | 0.260 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.516543e-01 | 0.258 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.542446e-01 | 0.256 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.542446e-01 | 0.256 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.542446e-01 | 0.256 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.542446e-01 | 0.256 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.542446e-01 | 0.256 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.542446e-01 | 0.256 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.571416e-01 | 0.254 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.571416e-01 | 0.254 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.586729e-01 | 0.253 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.586729e-01 | 0.253 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.618277e-01 | 0.250 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.669514e-01 | 0.246 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.669514e-01 | 0.246 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 5.669514e-01 | 0.246 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.669514e-01 | 0.246 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.685432e-01 | 0.245 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.685432e-01 | 0.245 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.685432e-01 | 0.245 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.685432e-01 | 0.245 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 5.685432e-01 | 0.245 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.685432e-01 | 0.245 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.685432e-01 | 0.245 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.685432e-01 | 0.245 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.685432e-01 | 0.245 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.685432e-01 | 0.245 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.685432e-01 | 0.245 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.685432e-01 | 0.245 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.685432e-01 | 0.245 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.685432e-01 | 0.245 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.687952e-01 | 0.245 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.717337e-01 | 0.243 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.717337e-01 | 0.243 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.787732e-01 | 0.237 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.787732e-01 | 0.237 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.793946e-01 | 0.237 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.793946e-01 | 0.237 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.793946e-01 | 0.237 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.872268e-01 | 0.231 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.872268e-01 | 0.231 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.872268e-01 | 0.231 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.872268e-01 | 0.231 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.872268e-01 | 0.231 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.872268e-01 | 0.231 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.881647e-01 | 0.231 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.886045e-01 | 0.230 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.900773e-01 | 0.229 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.915735e-01 | 0.228 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.966904e-01 | 0.224 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.970788e-01 | 0.224 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.970788e-01 | 0.224 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.971035e-01 | 0.224 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.975422e-01 | 0.224 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.982872e-01 | 0.223 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.982872e-01 | 0.223 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 6.025647e-01 | 0.220 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.034874e-01 | 0.219 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.034874e-01 | 0.219 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.034874e-01 | 0.219 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.034874e-01 | 0.219 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.034874e-01 | 0.219 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.034874e-01 | 0.219 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.051023e-01 | 0.218 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.051023e-01 | 0.218 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 6.051023e-01 | 0.218 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.051023e-01 | 0.218 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.051023e-01 | 0.218 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.051023e-01 | 0.218 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.051023e-01 | 0.218 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.051023e-01 | 0.218 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.051023e-01 | 0.218 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.051023e-01 | 0.218 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.053394e-01 | 0.218 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.078196e-01 | 0.216 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.122407e-01 | 0.213 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.122407e-01 | 0.213 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.151366e-01 | 0.211 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.151366e-01 | 0.211 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.172002e-01 | 0.210 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.191296e-01 | 0.208 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.194717e-01 | 0.208 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.199245e-01 | 0.208 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.222048e-01 | 0.206 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.222048e-01 | 0.206 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.222048e-01 | 0.206 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.222048e-01 | 0.206 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.222048e-01 | 0.206 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.222048e-01 | 0.206 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.265215e-01 | 0.203 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.265215e-01 | 0.203 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.266223e-01 | 0.203 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.266223e-01 | 0.203 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.373306e-01 | 0.196 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 6.373306e-01 | 0.196 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.376433e-01 | 0.195 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.376433e-01 | 0.195 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.376433e-01 | 0.195 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.376433e-01 | 0.195 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.376433e-01 | 0.195 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.376433e-01 | 0.195 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.385676e-01 | 0.195 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.385676e-01 | 0.195 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.385676e-01 | 0.195 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.385676e-01 | 0.195 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 6.444201e-01 | 0.191 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.444201e-01 | 0.191 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.475818e-01 | 0.189 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.485033e-01 | 0.188 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.531836e-01 | 0.185 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.542227e-01 | 0.184 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.542227e-01 | 0.184 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.542227e-01 | 0.184 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.542227e-01 | 0.184 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.542227e-01 | 0.184 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.542227e-01 | 0.184 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.542227e-01 | 0.184 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.591034e-01 | 0.181 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.591034e-01 | 0.181 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.677855e-01 | 0.175 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.677855e-01 | 0.175 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.692006e-01 | 0.174 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.692006e-01 | 0.174 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.692006e-01 | 0.174 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.692006e-01 | 0.174 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.692006e-01 | 0.174 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.692006e-01 | 0.174 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.692006e-01 | 0.174 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.694457e-01 | 0.174 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.694457e-01 | 0.174 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.702435e-01 | 0.174 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.718446e-01 | 0.173 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.785397e-01 | 0.168 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.795326e-01 | 0.168 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.795326e-01 | 0.168 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.835305e-01 | 0.165 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.872163e-01 | 0.163 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.893669e-01 | 0.162 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.893669e-01 | 0.162 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.893669e-01 | 0.162 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.893669e-01 | 0.162 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.893669e-01 | 0.162 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.930339e-01 | 0.159 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.930339e-01 | 0.159 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.930339e-01 | 0.159 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.960727e-01 | 0.157 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.972406e-01 | 0.157 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.972406e-01 | 0.157 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.972406e-01 | 0.157 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.972406e-01 | 0.157 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.972406e-01 | 0.157 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.972406e-01 | 0.157 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.100781e-01 | 0.149 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.103575e-01 | 0.149 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.103575e-01 | 0.149 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.103575e-01 | 0.149 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.103575e-01 | 0.149 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.173844e-01 | 0.144 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.173844e-01 | 0.144 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.173844e-01 | 0.144 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.173844e-01 | 0.144 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.173844e-01 | 0.144 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.176973e-01 | 0.144 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.176973e-01 | 0.144 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.229068e-01 | 0.141 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.229068e-01 | 0.141 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.229068e-01 | 0.141 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.250686e-01 | 0.140 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.294977e-01 | 0.137 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.322887e-01 | 0.135 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.322887e-01 | 0.135 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.348589e-01 | 0.134 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.349132e-01 | 0.134 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.349132e-01 | 0.134 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.349132e-01 | 0.134 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.354473e-01 | 0.133 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.363047e-01 | 0.133 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.462798e-01 | 0.127 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.464001e-01 | 0.127 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.464001e-01 | 0.127 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.464001e-01 | 0.127 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.464001e-01 | 0.127 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.464001e-01 | 0.127 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.464001e-01 | 0.127 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.464001e-01 | 0.127 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.476850e-01 | 0.126 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.536439e-01 | 0.123 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.570704e-01 | 0.121 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.573898e-01 | 0.121 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.573898e-01 | 0.121 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.573898e-01 | 0.121 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.573898e-01 | 0.121 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.573898e-01 | 0.121 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.573898e-01 | 0.121 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 7.573898e-01 | 0.121 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.661639e-01 | 0.116 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.679040e-01 | 0.115 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.679040e-01 | 0.115 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.679040e-01 | 0.115 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.679040e-01 | 0.115 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.679040e-01 | 0.115 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.745528e-01 | 0.111 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.745528e-01 | 0.111 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.745528e-01 | 0.111 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.779631e-01 | 0.109 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.779631e-01 | 0.109 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.779631e-01 | 0.109 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.779631e-01 | 0.109 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.779631e-01 | 0.109 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.779631e-01 | 0.109 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.779631e-01 | 0.109 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.779631e-01 | 0.109 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.818397e-01 | 0.107 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.875868e-01 | 0.104 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.875868e-01 | 0.104 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.875868e-01 | 0.104 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.875868e-01 | 0.104 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.875868e-01 | 0.104 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.957955e-01 | 0.099 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.967940e-01 | 0.099 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.967940e-01 | 0.099 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.967940e-01 | 0.099 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.967940e-01 | 0.099 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.024729e-01 | 0.096 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.024729e-01 | 0.096 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.024729e-01 | 0.096 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.024729e-01 | 0.096 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.024729e-01 | 0.096 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.024729e-01 | 0.096 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.056026e-01 | 0.094 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.056026e-01 | 0.094 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.056026e-01 | 0.094 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.056026e-01 | 0.094 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.070344e-01 | 0.093 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.089557e-01 | 0.092 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.089557e-01 | 0.092 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.102758e-01 | 0.091 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.130269e-01 | 0.090 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.140299e-01 | 0.089 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.140299e-01 | 0.089 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.140299e-01 | 0.089 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.140299e-01 | 0.089 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.152483e-01 | 0.089 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.213549e-01 | 0.085 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.213549e-01 | 0.085 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.220924e-01 | 0.085 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.220924e-01 | 0.085 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.220924e-01 | 0.085 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.284309e-01 | 0.082 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.298057e-01 | 0.081 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.371852e-01 | 0.077 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.371852e-01 | 0.077 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.371852e-01 | 0.077 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.371852e-01 | 0.077 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.371852e-01 | 0.077 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.371852e-01 | 0.077 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.386018e-01 | 0.076 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.442450e-01 | 0.074 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.509992e-01 | 0.070 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.509992e-01 | 0.070 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.509992e-01 | 0.070 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.509992e-01 | 0.070 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.509992e-01 | 0.070 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.509992e-01 | 0.070 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 8.516875e-01 | 0.070 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.516875e-01 | 0.070 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.535482e-01 | 0.069 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.571648e-01 | 0.067 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.574609e-01 | 0.067 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.574609e-01 | 0.067 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.592511e-01 | 0.066 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 8.601927e-01 | 0.065 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.636427e-01 | 0.064 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.636427e-01 | 0.064 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.636427e-01 | 0.064 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.642828e-01 | 0.063 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.642828e-01 | 0.063 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.682673e-01 | 0.061 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.695568e-01 | 0.061 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.695568e-01 | 0.061 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.695568e-01 | 0.061 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.752147e-01 | 0.058 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.752147e-01 | 0.058 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 8.752147e-01 | 0.058 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.752147e-01 | 0.058 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.752147e-01 | 0.058 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.774578e-01 | 0.057 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 8.796081e-01 | 0.056 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.806276e-01 | 0.055 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.806276e-01 | 0.055 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.806276e-01 | 0.055 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.807334e-01 | 0.055 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.815273e-01 | 0.055 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.816572e-01 | 0.055 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.858059e-01 | 0.053 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.858059e-01 | 0.053 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.892284e-01 | 0.051 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.907600e-01 | 0.050 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.954994e-01 | 0.048 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.954994e-01 | 0.048 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.954994e-01 | 0.048 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.000334e-01 | 0.046 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.027575e-01 | 0.044 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.043710e-01 | 0.044 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.043710e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.043710e-01 | 0.044 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.085206e-01 | 0.042 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.085206e-01 | 0.042 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.087872e-01 | 0.042 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.091083e-01 | 0.041 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.124905e-01 | 0.040 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.140643e-01 | 0.039 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.162882e-01 | 0.038 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.162882e-01 | 0.038 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.188012e-01 | 0.037 | 1 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.199214e-01 | 0.036 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.226465e-01 | 0.035 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.242370e-01 | 0.034 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.267222e-01 | 0.033 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.299031e-01 | 0.032 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.299031e-01 | 0.032 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.332631e-01 | 0.030 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.396425e-01 | 0.027 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.413062e-01 | 0.026 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.413062e-01 | 0.026 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.413062e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.413062e-01 | 0.026 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.462929e-01 | 0.024 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.503242e-01 | 0.022 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.503314e-01 | 0.022 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.508565e-01 | 0.022 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.517896e-01 | 0.021 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.523372e-01 | 0.021 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.529910e-01 | 0.021 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.529910e-01 | 0.021 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.529910e-01 | 0.021 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.535334e-01 | 0.021 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.547265e-01 | 0.020 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.550328e-01 | 0.020 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.550328e-01 | 0.020 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.569861e-01 | 0.019 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.576051e-01 | 0.019 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.588547e-01 | 0.018 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.589792e-01 | 0.018 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.606422e-01 | 0.017 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.632475e-01 | 0.016 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.639878e-01 | 0.016 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.641518e-01 | 0.016 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.674893e-01 | 0.014 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.684659e-01 | 0.014 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.684814e-01 | 0.014 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.684814e-01 | 0.014 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.698512e-01 | 0.013 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.698512e-01 | 0.013 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.703529e-01 | 0.013 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.703529e-01 | 0.013 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.711615e-01 | 0.013 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.711615e-01 | 0.013 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.714050e-01 | 0.013 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.724150e-01 | 0.012 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.736140e-01 | 0.012 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.743135e-01 | 0.011 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.762814e-01 | 0.010 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.769078e-01 | 0.010 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.788722e-01 | 0.009 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.797909e-01 | 0.009 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.798384e-01 | 0.009 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.803796e-01 | 0.009 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.811063e-01 | 0.008 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.816058e-01 | 0.008 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.817452e-01 | 0.008 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.823145e-01 | 0.008 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.823635e-01 | 0.008 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.824997e-01 | 0.008 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.837878e-01 | 0.007 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.846423e-01 | 0.007 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.855058e-01 | 0.006 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.858281e-01 | 0.006 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.863151e-01 | 0.006 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.883532e-01 | 0.005 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.885781e-01 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.891578e-01 | 0.005 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.896297e-01 | 0.005 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.900811e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.900811e-01 | 0.004 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.920601e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.924059e-01 | 0.003 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.945295e-01 | 0.002 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.949432e-01 | 0.002 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.951383e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.951910e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.955067e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.955498e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.959292e-01 | 0.002 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.969201e-01 | 0.001 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.970202e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.986988e-01 | 0.001 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.988674e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.988882e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.998018e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998438e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999202e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999366e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999442e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999657e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999883e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999889e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999890e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999960e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999965e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999983e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999991e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |